Results 81 to 90 of about 1,819,904 (233)
Use of drug-eluting vs. bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study [PDF]
, 2015 INTRODUCTION AND OBJECTIVES: The interventional cardiologist chooses a specific stent type based on the risk-benefit profile for each case. In general, drug-eluting stents should be considered in all clinical conditions, except if there are concerns or ...
Azevedo, A +4 more
core +1 more source
Reviews in Cardiovascular Medicine, 2010 Significant evolution in catheter-based technologies for percutaneous coronary intervention has occurred since the introduction of coronary balloon angioplasty by Andreas Grüntzig in 1977. As balloon angioplasty was supplanted by bare metal stents and subsequently drug-eluting stents (DES), randomized comparative clinical trials have demonstrated a ...
openaire +2 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Intravascular lithotripsy (IVL) has emerged as an effective technique for modifying heavily calcified coronary plaques, facilitating optimal stent expansion while minimizing procedural complications. However, data on periprocedural myocardial injury (PMI) and infarction (PPMI) following IVL remain scarce.
Gwaenaelle Aellen +5 more
wiley +1 more source
Coating stent materials with polyhedral oligomeric silsesquioxane-poly(carbonateurea)urethane nanocomposites [PDF]
, 2009 The long-term efficacy of coronary or peripheral stenting is limited by in-stent restenosis (ISR), which occurs in 15 to 30% of patients and is attributed primarily to neointimal hyperplasia.
Bakhshi, R.
core
Development and Examination of Coated Coronary Stents [PDF]
, 2007 The aim of this study is to show the developments carried out by us with coated stents, expansion properties, furthermore the failures of the coatings. The coating was examined before and after expansion, paying special attention to the curves.
Dobránszky, János +3 more
core +2 more sources
Drug eluting stents a nightmare? [PDF]
Interactive CardioVascular and Thoracic Surgery, 2007 As a contribution to the controversial discussion for the use of drug-eluting stents, the European Heart Institute of the European Academy of Sciences and Arts is emphasizing important factors: a) drug eluting stents (DES) should be used only in accordance with their on-label indications for use; b) to avoid off-label use of DES and to assure that ...
openaire +2 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Incomplete stent apposition at the proximal coronary artery may predispose to subtle guiding catheter–induced stent deformation, creating a gap between the stent and the vessel wall that facilitates inadvertent abluminal guidewire passage. We report a case in which balloon dilatation over an unrecognized abluminal guidewire resulted in severe ...
Yuto Abe +3 more
wiley +1 more source
Food Biomacromolecules, EarlyView.Abstract Cardiovascular diseases (CVDs) remain the leading cause of global mortality, necessitating effective preventive and adjunct therapeutic strategies beyond conventional pharmacological interventions. Although previous reviews have focused on individual nutrients or dietary patterns, this review provides a mechanism‐based, integrative perspective
Sridevi Shanmugam +7 more
wiley +1 more source
Immediate Small Side Branch Occlusion after Percutaneous Coronary Intervention [PDF]
Journal of Tehran University Heart Center, 2007 Background: Small side branches, albeit less important than their larger counterparts, have not yet received due attention in the literature. Nor has there ever been a comparison between drug-eluting stents and bare metal stents apropos side branch ...
Mohammad Ali Ostovan, Reza Mollazadeh
doaj +1 more source
NPG Asia MaterialsDrug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity.
Feng Zhao +14 more
doaj +1 more source